Flosonics Medical

Flosonics Medical supports its hemodynamic devices with clinical evidence and research.

The page explains how Sepsis Emergency Response Teams use Point-of-Care Ultrasound and FloPatch for fluid management in sepsis care.

A large public hospital in the Greater Los Angeles Area improved sepsis outcomes and reduced complications by implementing FloPatch for precision fluid management, achieving significant enhancements in SEP-1 compliance, reduced ICU admissions, and shorter ICU stays.

A dynamic assessment with FloPatch was performed on an 82-year-old male with sepsis-related hypotension, enabling precise fluid management and avoiding the need for invasive central line placement.

In a complex case, a FloPatch assessment led to a nuanced fluid management strategy for a 48-year-old post-hysterectomy, guiding the shift to vasoactive drugs and preventing potential complications from further fluid resuscitation.

Flosonics Medical highlights a new study in SAGE Open Medicine showcasing how nursing-led sepsis response teams at RUHS use FloPatch and POCUS to enhance protocol compliance and personalize fluid resuscitation—redefining sepsis care.

The funds will be used to pursue the commercialization of Flosonics Medical’s wireless Doppler ultrasound patch in addition to new product development

The Government of Canada investment will support the research and development of FloPatch, clinical trials, and preliminary market development

The Government of Canada investment will help Flosonics Medical develop the IT infrastructure required for commercialization and create five new jobs in Greater Sudbury

The funds will be used to develop and commercialize FloPatch, a wearable wireless Doppler ultrasound sensor that enables rapid, repeatable, and trusted hemodynamic assessments

Flosonics Medical develops hemodynamic medical devices to enhance patient care.

Dr. Eibl is responsible for the growth and development of technology, intellectual property and business strategy. Dr. Eibl holds a PhD in Biomolecular Sciences and he has conducted postdoctoral training in the field of bioengineering.

Flosonics Medical designs hemodynamic devices and focuses on advancing patient care.

FloPatch - the first wireless, wearable ultrasound, providing real-time hemodynamic assessments to help make informed decisions on fluid resuscitation.

This Privacy Policy describes how your personal information is collected, used, and shared when you visit flosonicsmedical.com (the “Site”).

Flosonics Medical improves digital accessibility on its website to meet WCAG 2.1 Level AA standards.

Denka Co. invests in Flosonics Medical, a Canadian startup creating wearable ultrasound devices. The funding comes through a joint corporate venture capital fund with Pegasus Tech Ventures. Flosonics develops FloPatch, a wearable ultrasound solution for medical applications.

Jul 2026International Business Times JapanNews article

Flosonics Medical secures an Innovative Technology contract from Vizient for its FloPatch wearable Doppler ultrasound device. Vizient, the largest provider-driven healthcare performance improvement company in the U.S., selected FloPatch after expert review for its potential to enhance fluid management and sepsis patient outcomes. The contract follows validation by hospital experts on Vizient’s client-led councils.

Mar 2026thecanadianpressnews.caNews article

Flosonics Medical deploys its FloPatch wireless Doppler ultrasound device at The Mount Sinai Hospital’s surgical and transplant ICUs. This marks the company’s first East Coast adoption, broadening its U.S. presence in critical-care monitoring. FloPatch enables real-time, patient-specific fluid management in intensive care settings.

Jun 2025OBIONews article

Flosonics Medical secures C$7.5 million in venture debt from RBCx to expand its wearable ultrasound technology. The company develops noninvasive, data-driven medical devices that enable clinicians to make quicker diagnostic decisions at the point of care. This funding supports scaling production and adoption of its transformative wearable solutions.

Mar 2025Pulse 2.0News article